PubMed

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease.

Bell LN, Theodorakis JL, Vuppalanchi R, Saxena R, Bemis KG, Wang M, Chalasani N.

Hepatology. 2009 Sep 9. [Epub ahead of print]PMID: 19885878 [PubMed - as supplied by publisher]Related articles

Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events.

Lammert C, Bjornsson E, Niklasson A, Chalasani N.

Hepatology. 2009 Sep 14. [Epub ahead of print]PMID: 19839004 [PubMed - as supplied by publisher]Related articles

Epidemiology of idiosyncratic drug-induced liver injury.

Bell LN, Chalasani N.

Semin Liver Dis. 2009 Nov;29(4):337-47. Epub 2009 Oct 13.PMID: 19826967 [PubMed - in process]Related articles

Variability in the upper limit of normal for serum alanine aminotransferase levels: A statewide study.

Dutta A, Saha C, Johnson CS, Chalasani N.

Hepatology. 2009 Aug 5. [Epub ahead of print]PMID: 19787805 [PubMed - as supplied by publisher]Related articles

Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time!

Chalasani N.

Gastroenterology. 2009 Sep;137(3):772-5. Epub 2009 Jul 26. No abstract available. PMID: 19638269 [PubMed - indexed for MEDLINE]Related articles

Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.

Lee L, Alloosh M, Saxena R, Van Alstine W, Watkins BA, Klaunig JE, Sturek M, Chalasani N.

Hepatology. 2009 Jul;50(1):56-67.PMID: 19434740 [PubMed - indexed for MEDLINE]Related articles

Drug-induced liver injury in clinical trials: as rare as hens' teeth.

Davern TJ, Chalasani N.

Am J Gastroenterol. 2009 May;104(5):1159-61. Epub 2009 Apr 7. Review.PMID: 19352346 [PubMed - indexed for MEDLINE]Related articles

Initial experience with EUS-guided Tru-cut biopsy of benign liver disease.

Dewitt J, McGreevy K, Cummings O, Sherman S, Leblanc JK, McHenry L, Al-Haddad M, Chalasani N.

Gastrointest Endosc. 2009 Mar;69(3 Pt 1):535-42.PMID: 19231495 [PubMed - indexed for MEDLINE]Related articles

Nonalcoholic fatty liver disease and cardiovascular risk.

Misra VL, Khashab M, Chalasani N.

Curr Gastroenterol Rep. 2009 Feb;11(1):50-5.PMID: 19166659 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

Vuppalanchi R, Unalp A, Van Natta ML, Cummings OW, Sandrasegaran KE, Hameed T, Tonascia J, Chalasani N.

Clin Gastroenterol Hepatol. 2009 Apr;7(4):481-6. Epub 2008 Dec 25.PMID: 19162235 [PubMed - indexed for MEDLINE]Related articlesFree article

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.

Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J; DILIN Study Group.

Drug Saf. 2009;32(1):55-68. doi: 10.2165/00002018-200932010-00005.PMID: 19132805 [PubMed - indexed for MEDLINE]Related articles

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.

Vuppalanchi R, Chalasani N.

Hepatology. 2009 Jan;49(1):306-17. Review.PMID: 19065650 [PubMed - indexed for MEDLINE]Related articlesFree article

What advice should be given to patients with NAFLD about the consumption of alcohol?

Sozio MS, Chalasani N, Liangpunsakul S.

Nat Clin Pract Gastroenterol Hepatol. 2009 Jan;6(1):18-9. Epub 2008 Nov 18. No abstract available. PMID: 19015652 [PubMed - indexed for MEDLINE]Related articles

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN).

Gastroenterology. 2008 Dec;135(6):1924-34, 1934.e1-4. Epub 2008 Sep 17.PMID: 18955056 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.

Chalasani NP, Sanyal AJ, Kowdley KV, Robuck PR, Hoofnagle J, Kleiner DE, Unalp A, Tonascia J; NASH CRN Research Group.

Contemp Clin Trials. 2009 Jan;30(1):88-96. Epub 2008 Sep 10.PMID: 18804555 [PubMed - indexed for MEDLINE]Related articles

Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report.

Malireddy SR, Pinto AG, Chalasani NP, Gorski JC, Hall SD.

Transplant Proc. 2008 Jun;40(5):1789-91.PMID: 18589198 [PubMed - indexed for MEDLINE]Related articles

Obstructive sleep apnea and nonalcoholic fatty liver disease: causal association or just a coincidence?

Misra VL, Chalasani N.

Gastroenterology. 2008 Jun;134(7):2178-9. Epub 2008 May 15. No abstract available. PMID: 18485910 [PubMed]Related articles

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.

Lammert C, Einarsson S, Saha C, Niklasson A, Bjornsson E, Chalasani N.

Hepatology. 2008 Jun;47(6):2003-9.PMID: 18454504 [PubMed - indexed for MEDLINE]Related articles

Deep vein thrombosis and pulmonary embolism in cirrhosis patients.

Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S.

Dig Dis Sci. 2008 Nov;53(11):3012-7. Epub 2008 Apr 29.PMID: 18443906 [PubMed - indexed for MEDLINE]Related articles

Nonalcoholic fatty liver disease as a component of the metabolic syndrome.

Khashab MA, Liangpunsakul S, Chalasani N.

Curr Gastroenterol Rep. 2008 Feb;10(1):73-80. Review.PMID: 18417046 [PubMed - indexed for MEDLINE]Related articles

Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.

Chalasani N, Wilson L, Kleiner DE, Cummings OW, Brunt EM, Unalp A; NASH Clinical Research Network.

J Hepatol. 2008 May;48(5):829-34. Epub 2008 Feb 12.PMID: 18321606 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin resistance, hepatitis C, and liver transplantation.

Alsatie M, Pandya P, Chalasani NP.

Liver Transpl. 2008 Feb;14(2):136-7. No abstract available. PMID: 18236446 [PubMed - indexed for MEDLINE]Related articlesFree article

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.

Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K.

Hepatology. 2008 Feb;47(2):484-92.PMID: 18220286 [PubMed - indexed for MEDLINE]Related articles

Use of insulin sensitizers in NASH.

Khashab M, Chalasani N.

Endocrinol Metab Clin North Am. 2007 Dec;36(4):1067-87; xi. Review.PMID: 17983937 [PubMed - indexed for MEDLINE]Related articles

Noninvasive markers of advanced histology in nonalcoholic fatty liver disease: are we there yet?

Wilson S, Chalasani N.

Gastroenterology. 2007 Oct;133(4):1377-8; discussion 1378-9. No abstract available. PMID: 17919509 [PubMed]Related articles

Lipid-lowering agents that cause drug-induced hepatotoxicity.

Bhardwaj SS, Chalasani N.

Clin Liver Dis. 2007 Aug;11(3):597-613, vii. Review.PMID: 17723922 [PubMed - indexed for MEDLINE]Related articlesFree article

HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.

Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote EJ, Miskovsky E, Shaffer E, Rulyak SJ, Kowdley KV.

Hepatology. 2007 Sep;46(3):723-9.PMID: 17680648 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome following liver transplantation is associated with major vascular events.

Liangpunsakul S, Chalasani NP.

Liver Transpl. 2007 Aug;13(8):1078-9. No abstract available. PMID: 17663405 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.

Shen H, Agarwal D, Qi R, Chalasani N, Liangpunsakul S, Lumeng L, Yoo H, Kwo P.

Aliment Pharmacol Ther. 2007 Aug 1;26(3):393-400.PMID: 17635374 [PubMed - indexed for MEDLINE]Related articlesFree article

Validation of a multivariate model predicting presence and size of varices.

Burton JR Jr, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A.

J Clin Gastroenterol. 2007 Jul;41(6):609-15.PMID: 17577118 [PubMed - indexed for MEDLINE]Related articles

How common is chronic liver disease from acute drug-induced liver injury?

Hanje AJ, Chalasani N.

Gastroenterology. 2007 May;132(5):2067-8; discussion 2068-9. No abstract available. PMID: 17484903 [PubMed]Related articles

Management of hepatitis C infection after liver transplantation.

Alsatie M, Chalasani N, Kwo PY.

Drugs. 2007;67(6):871-85. Review.PMID: 17428105 [PubMed - indexed for MEDLINE]Related articles

Therapeutic doses of acetaminophen frequently cause elevated aminotransferases in healthy volunteers: is it significant?

Vuppalanchi R, Chalasani N.

Gastroenterology. 2007 Apr;132(4):1624-6. No abstract available. PMID: 17408645 [PubMed]Related articles

Are there ethnicity-based differences in the evaluation of individuals with abnormal liver biochemistries?

Chalasani N, Saha C, Teal E.

J Hepatol. 2007 Jul;47(1):123-7. Epub 2007 Mar 2.PMID: 17399845 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.

Imperiale TF, Klein RW, Chalasani N.

Hepatology. 2007 Apr;45(4):870-8.PMID: 17393528 [PubMed - indexed for MEDLINE]Related articles

Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.

Kolwankar D, Vuppalanchi R, Ethell B, Jones DR, Wrighton SA, Hall SD, Chalasani N.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):388-93.PMID: 17368239 [PubMed - indexed for MEDLINE]Related articles

Macro-aspartate aminotransferase and monoclonal gammopathy: a review of two cases.

Werner T, Vargas HE, Chalasani N.

Dig Dis Sci. 2007 May;52(5):1197-8. Epub 2007 Mar 15. No abstract available. PMID: 17357839 [PubMed - indexed for MEDLINE]Related articles

Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples.

Vuppalanchi R, Cummings OW, Saxena R, Ulbright TM, Martis N, Jones DR, Bansal N, Chalasani N.

J Clin Gastroenterol. 2007 Feb;41(2):206-10.PMID: 17245221 [PubMed - indexed for MEDLINE]Related articles

Complete reversal of glycogen hepatopathy with pancreas transplantation: two cases.

Fridell JA, Saxena R, Chalasani NP, Goggins WC, Powelson JA, Cummings OW.

Transplantation. 2007 Jan 15;83(1):84-6.PMID: 17220798 [PubMed - indexed for MEDLINE]Related articles

Opioids induce renal abnormalities in tumor-bearing mice.

Arerangaiah R, Chalasani N, Udager AM, Weber ML, Manivel JC, Griffin RJ, Song CW, Gupta K.

Nephron Exp Nephrol. 2007;105(3):e80-9. Epub 2007 Jan 12.PMID: 17220637 [PubMed - indexed for MEDLINE]Related articles

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

Vuppalanchi R, Liangpunsakul S, Chalasani N.

Am J Gastroenterol. 2007 Mar;102(3):558-62; quiz 693.PMID: 17156142 [PubMed - indexed for MEDLINE]Related articles

Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.

Vuppalanchi R, Chalasani N, Saxena R.

Am J Surg Pathol. 2006 Dec;30(12):1619-23.PMID: 17122520 [PubMed - indexed for MEDLINE]Related articles

Autoimmune hepatitis triggered by statins.

Alla V, Abraham J, Siddiqui J, Raina D, Wu GY, Chalasani NP, Bonkovsky HL.

J Clin Gastroenterol. 2006 Sep;40(8):757-61.PMID: 16940892 [PubMed - indexed for MEDLINE]Related articles

Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices.

Vuppalanchi R, Chalasani N.

Gastroenterology. 2006 Aug;131(2):674-6; discussion 676. No abstract available. PMID: 16890623 [PubMed]Related articles

Statins for hyperlipidemia in patients with chronic liver disease: are they safe?

Vuppalanchi R, Chalasani N.

Clin Gastroenterol Hepatol. 2006 Jul;4(7):838-9. No abstract available. PMID: 16829348 [PubMed - indexed for MEDLINE]Related articles

Severe liver injury after initiating therapy with atomoxetine in two children.

Lim JR, Faught PR, Chalasani NP, Molleston JP.

J Pediatr. 2006 Jun;148(6):831-4.PMID: 16769398 [PubMed - indexed for MEDLINE]Related articles

Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.

Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA.

J Clin Endocrinol Metab. 2006 Jun;91(6):2279-85. Epub 2006 Apr 4.PMID: 16595594 [PubMed - indexed for MEDLINE]Related articlesFree article

An assessment of statin safety by hepatologists.

Cohen DE, Anania FA, Chalasani N; National Lipid Association Statin Safety Task Force Liver Expert Panel.

Am J Cardiol. 2006 Apr 17;97(8A):77C-81C. Epub 2006 Feb 3.PMID: 16581333 [PubMed - indexed for MEDLINE]Related articles

Bleeding caused by portal hypertension.

Zaman A, Chalasani N.

Gastroenterol Clin North Am. 2005 Dec;34(4):623-42. Review.PMID: 16303574 [PubMed - indexed for MEDLINE]Related articles

Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.

Chalasani N, Teal E, Hall SD.

Am J Gastroenterol. 2005 Jun;100(6):1317-21.PMID: 15929763 [PubMed - indexed for MEDLINE]Related articles